Day: August 29, 2023

MachTen, Inc. Reports Results for the Second Quarter 2023

TRAVERSE CITY, Mich., Aug. 29, 2023 (GLOBE NEWSWIRE) — MachTen, Inc. (“MACT”) (OTC: MACT) today reported its operating results for the quarter ended June 30, 2023. Financial Highlights (In thousands)   Three Months Ended     June 30,2023   June 30,2022           Regulated revenue   $ 3,035     $ 3,069   Non-regulated revenue   $ 950     $ 885   Operating profit   $ 1,435     $ 1,478   Net income   $ 1,060     $ 1,053             Revenue        Regulated revenue declined to $3.04 million in the 2nd quarter of 2023 from $3.07 million in the same period last year, primarily attributable to the elimination of a Michigan Universal Service Fund (USF) program. As a result of this program’s elimination in mid-2022, intrastate access and USF revenue declined to $18,000 in the 2nd quarter, compared to $91,000 in the prior...

Continue reading

SHARC Energy Announces Q2 2023 Financial Results

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) announces it has filed financial results for the six months ended June 30, 2023. All figures are in Canadian Dollars and in accordance with IFRS unless otherwise stated. Second Quarter and Year-to-date Financial Highlights: As of August 29, 2023, the Company has a Sales Pipeline1 of 16.7 million (M) and Sales Order Backlog2 of $1.3M. This represents minor growth in Sales Pipeline and a 20% increase in Sales Order Backlog. The increase in Sales Order Backlog is due to the completion of submittals and receiving purchase orders on deals previously disclosed in Sales Pipeline. Working capital of $4.2M, which includes $3.1M of cash, as of June 30, 2023. The...

Continue reading

Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients through development of novel DNA-damage response inhibitor therapeutics, announced financial results for the quarter ended June 30, 2023, and provided a corporate update. Corporate highlights during the past quarter included: The publication of a paper in the Journal of Clinical Oncology describing pre-clinical data for our lead pre-clinical candidate, kt-3283, demonstrating kt-3283’s potential to treat cancers that are resistant to first-generation PARP inhibitors. We believe these data support the potential to address unmet medical needs in the treatment of a range of treatment-resistant cancers including Ewing sarcoma, breast cancer,...

Continue reading

OceanPal Inc. Becomes Strategic Partner In Two 6,600dwt Methanol-Ready Chemical Tanker Newbuildings

ATHENS, Greece, Aug. 29, 2023 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, announced that the Company today agreed to become a strategic partner and invest in a Norwegian entity, RFSea Infrastructure II AS, that will construct, at Wuhu Shipyard Co., Ltd. (China), under two separate newbuilding contracts, two 6,600 dwt methanol-ready, stainless steel chemical tankers with expected deliveries during the fourth quarter of 2025 and the first quarter of 2026, respectively. The transaction remains subject to the satisfaction of customary closing conditions. The Company is partnering with a private London-based alternative investment and commercial management firm focusing on the maritime industry and other partners and investors. Fearnley Securities...

Continue reading

Certara Simcyp™ Group Awarded Two New Grants from US FDA

Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) — Certara (Nasdaq: CERT), a global leader in biosimulation, today announced that the Simcyp group has been awarded two new grants from the U.S. Food and Drug Administration (FDA) to expand its predictive models for assessing drug virtual bioequivalence (VBE) and to create a formulation toolbox for topically applied drugs. These capabilities will help enable safer, faster and more cost-effective product development of both complex generics and novel drugs. “We are proud to collaborate with the FDA in developing innovative model-informed approaches for accelerating drug development of complex generic and innovator...

Continue reading

Rumpl Partners with Nogin To Supercharge D2C Growth

Rumpl to leverage Nogin’s Commerce-as-a-Service solution to drive rapid direct-to-consumer growth and amplify brand reach TUSTIN, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Nogin (Nasdaq: NOGN), a pioneer in Commerce-as-a-Service (“CaaS”), today announced that Rumpl, the category leader in technical blankets, has chosen Nogin’s Intelligent Commerce technology and services to grow its direct-to-consumer (D2C) business. Nogin’s enterprise-class technology and deep ecommerce expertise will drive accelerated growth for Rumpl as it continues to redefine the category of blankets and technical comfort products. Founded on a surf and ski trip through California, Rumpl specializes in producing sustainable, high-performance outdoor blankets using innovative materials and designs. Delivering a blend of functionality and style, Rumpl’s...

Continue reading

CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology

The code is effective as of October 1, 2023 Durham, NC, Aug. 29, 2023 (GLOBE NEWSWIRE) — Polarean (AIM: POLX), a commercial-stage medical device leader in advanced MRI scanning of the lungs, announces that the Centers for Medicare & Medicaid Services (CMS) has established a new reimbursement code for the Polarean XENOVIEW™ (xenon Xe 129, hyperpolarized) technology, effective October 1, 2023. The code (C9791) enables healthcare providers a path to bill for “magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent”. This was announced as part of the release of the October 2023 Healthcare Common Procedure Coding System (HCPCS) code set. The payment level associated with the XENOVIEW™ MRI code is yet to be announced and is expected...

Continue reading

GOGL – Q2 2023 Presentation

Please find enclosed the presentation of Golden Ocean Group Limited’s second quarter 2023 results for today’s webcast / conference call at 15:00 CEST. Attend by Webcast: Use the follow link prior to the webcast: GOGL Q2 2023 Webcast Attend by Conference Call: Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered. GOGL Q2 2023 Conference Call A Q&A session will be held after the conference call/webcast. Information on how to submit questions will be given at the beginning of the session. The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the...

Continue reading

StepStone Group to Present at the Barclays Global Financial Services Conference

NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Barclays Global Financial Services Conference on Tuesday, September 12, 2023 at 2:45 pm ET. A live webcast and replay will be accessible through the StepStone website at https://shareholders.stepstonegroup.com. About StepStone StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory, data and administrative services to its clients. As of June 30, 2023, StepStone was responsible for approximately $640 billion of total capital, including $143 billion of assets under management. StepStone’s clients include some of the world’s largest public and private...

Continue reading

BIGG Digital Assets Inc. Portfolio Company TerraZero Technologies to Launch New Subscription-Based Platform Intraverse PRO

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), owner of Netcoins, Blockchain Intelligence Group, an investor in TerraZero Technologies Inc. (“TerraZero”), a vertically integrated Metaverse development group and leading web3 technology company specializing in helping brands create immersive experiences, announces their plans to release Intraverse PRO. This addition to the TerraZero portfolio sets the stage for unparalleled omni-channel connectivity, solidifying the company’s commitment to delivering cutting-edge solutions for modern businesses, now with a significant focus on artists, creators and SMBs with Intraverse PRO. “We are thrilled to usher in a new era of immersive virtual experiences...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.